Magnitude Of Benefit Of The Addition Of Bevacizumab (Beva) To First-Line Chemotherapy (Ct) For Advanced/Metastatic Colorectal Cancer (Mcrc): Meta-Analysis Of Randomized Clinical Trials
JOURNAL OF CLINICAL ONCOLOGY（2009）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要